MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-29-0043353
Medisra Pharma Private Limited
Medisra Pharma Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.34 Cr
▲ 15% YoY
Net profit · FY 2025
₹38,828
Net margin 0.3%
EBITDA · FY 2025
₹3.44 Lakh
EBITDA margin 2.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Medisra Pharma Private Limited
Data last updated:
Medisra Pharma Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909HR2019PTC082141. Its GSTIN is 09AAMCM8924E1Z3 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajesh Singh and Leena Khera.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 129 F Blossom II Sector 51, Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.34 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹38,828 (net margin 0.3%) and EBITDA of ₹3.44 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 22% over five years.
Medisra Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0043353).
Company details
CIN U51909HR2019PTC082141
Registration Number 082141
Incorporation Date 22 August 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0043353
Key People
Ajesh Singh Director Leena Khera Director Recognitions & Rankings of Medisra Pharma
Contact details
Medisra Pharma Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM – 129 F Blossom II Sector 51, Gurgaon, Haryana, India – 122001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medisra Pharma Private Limited, buy the company report.
Comprehensive company report
Medisra Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medisra Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medisra Pharma Private Limited, buy the company report.
Financials of Medisra Pharma Private Limited
FY 2025 filings availableMedisra Pharma Private Limited reported revenue of ₹1.34 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹1.34 Cr ▲ 15%
Net profit · FY 2025
₹38,828 margin 0.3%
EBITDA · FY 2025
₹3.44 Lakh margin 2.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 6%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 36%
5 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 15% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38,828 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medisra Pharma Private Limited, buy the company report.
Board of directors of Medisra Pharma Private Limited
Medisra Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajesh Singh Also directs: Tetrique Pharmaceuticals Private Limited | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
| Leena Khera | Director | 22 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Medisra Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medispin Pharmaceutical Private Limited | ₹1.35 Cr (FY 2024) | 23.0% | Nashik, Maharashtra, India | |||
| Wellwish Pharma Private Limited | ₹1.34 Cr (FY 2024) | -9.0% | Nagpur, Maharashtra, India | |||
| Medisra Pharma Private Limitedthis company | ₹1.34 Cr (FY 2025) | ₹38,828 | 0.3% | 15.0% | Gurgaon, Haryana, India | |
| Sarck Life Sciences Private Limited | ₹1.34 Cr (FY 2022) | 50.0% | Muzaffarpur, Bihar, India | |||
| Arakind Health Care Private Limited | ₹1.34 Cr (FY 2024) | 83.0% | Lko, Uttar Pradesh, India | |||
| Shreeji Pharmaworld Private Limited | ₹1.34 Cr (FY 2025) | -6.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Medisra Pharma Private Limited, buy the company report.
Auditor
Medisra Pharma Private Limited is audited by GAURAV GARG & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV GARG & ASSOCIATES | FY 2022 | 029722N |
Shareholding
The shareholding of Medisra Pharma Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medisra Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medisra Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medisra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medisra Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCM8924E1Z3 | Uttar Pradesh | Active | 12 Sep 2019 |
To see the full GST registrations and return filing status of Medisra Pharma Private Limited, buy the company report.
Recent activity
Medisra Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Ajesh Singh ceased to be Additional Director on 30 Sep 2022.
AGM
Medisra Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medisra Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Ajesh Singh ceased to be Additional Director.
Appointed
Ajesh Singh was appointed as Director.
Ceased
Veena Khera ceased to be Director.
Appointed
Leena Khera was appointed as Director.
Incorporation
22 Aug 2019
Medisra Pharma Private Limited was registered on 22 Aug 2019 with Roc Delhi & aged 7 years 2 months as per MCA records.
Frequently asked questions
Medisra Pharma is an active private limited company based in Gurgaon, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 August 2019 (7+ years old) and is registered under CIN U51909HR2019PTC082141.
Medisra Pharma has 2 current directors:
- Ajesh Singh - Director
- Leena Khera - Director
The latest financial statements of Medisra Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Medisra Pharma is 09AAMCM8924E1Z3, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medisra Pharma is U51909HR2019PTC082141. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medisra Pharma was incorporated on 22 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medisra Pharma by revenue are Medispin Pharmaceutical Private Limited, Wellwish Pharma Private Limited, Sarck Life Sciences Private Limited, Arakind Health Care Private Limited, Shreeji Pharmaworld Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ajesh Singh ceased to be Additional Director on 30 Sep 2022. Ajesh Singh was appointed as Director on 31 Mar 2022. Veena Khera ceased to be Director on 31 Mar 2022. Medisra Pharma has 4 board changes on record in total.
Yes, Medisra Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0043353).
The registered office of Medisra Pharma is at M – 129 F Blossom II Sector 51, Gurgaon, Haryana, India – 122001.
Medisra Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages